Lovell Jones

The Scientist Date: August 19, 1996 THE SCIENTIST® The Newspaper for the Life Sciences Professional "THE SCIENTIST is focused on areas that most other publications shy away from....They are issues you see in other periodicals, but they don't have the breadth in terms of looking at their impact on minority and medically underserved populations." Lovell Jones, director, Section of Experimental Gynecology/Endocrinology,Department of Gynecologic Oncology, University of Texas M.D. Anderson C

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Scientist

Date: August 19, 1996

Lovell Jones, director, Section of Experimental Gynecology/Endocrinology,
Department of Gynecologic Oncology,
University of Texas M.D. Anderson Cancer Center, Houston

"We're now the only multicultural group with a liaison to the advisory council of the National Cancer Institute," Jones notes. "We've been instrumental in setting up an office of special populations at NCI as well as meeting with Congress to see about setting up more effective research. This message has gotten through on both sides of the aisle. It gets at who they ask for advice. You can be bilingual but not bicultural."

An avid reader of THE SCIENTIST, Jones says: "THE SCIENTIST is focused on areas that most other publications shy away from-the reorganization of the NCI, the pros and cons of clinical trials, and the impact on managed care. They are issues you see in other periodicals, but they don't have the breadth in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies